Asset Details
Do you wish to reserve the book?
Therapeutic options for premature ovarian insufficiency: an updated review
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Therapeutic options for premature ovarian insufficiency: an updated review
Do you wish to request the book?
Therapeutic options for premature ovarian insufficiency: an updated review
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Therapeutic options for premature ovarian insufficiency: an updated review
2022
Overview
Primary ovarian insufficiency (POI) is a rare gynecological condition. This disease causes menstrual disturbances, infertility, and various health problems. Historically, hormone replacement therapy is the first-line treatment for this disorder. Women diagnosed with POI are left with limited therapeutic options. In order to remedy this situation, a new generation of therapeutic approaches, such as in vitro activation, mitochondrial activation technique, stem cell and exosomes therapy, biomaterials strategies, and platelet-rich plasma intra-ovarian infusion, is being developed. However, these emerging therapies are yet in the experimental stage and require precise design components to accelerate their conversion into clinical treatments. Thus, each medical practitioner bears responsibility for selecting suitable therapies for individual patients. In this article, we provide a timely analysis of the therapeutic strategies that are available for POI patients and discuss the prospects of POI therapy.
Publisher
BioMed Central,BioMed Central Ltd,BMC
Subject
/ Exosomes
/ Female
/ Hormone Replacement Therapy - methods
/ Hormone Replacement Therapy - trends
/ Humans
/ Kinases
/ Medicine
/ Mitochondrial activation technique
/ Ovaries
/ Patients
/ Platelet-Rich Plasma - physiology
/ Premature ovarian insufficiency
/ Primary Ovarian Insufficiency - epidemiology
/ Primary Ovarian Insufficiency - therapy
/ Proteins
/ Review
/ Therapies, Investigational - methods
